Key Takeaways GLP-1 medications are associated with a higher risk of gallstones and gallbladder disease, and FDA labeling for Zepbound and Wegovy lists gallstones and acute cholecystitis as possible risks
DOI: 10.1159/000322975 Epub 2011 Apr 5 15
Your individual genetic profile, as revealed by the PlexusDx Precision Peptide Genetic Test, can help describe the pathway-level variants involved
On December 11, 2025, Eli Lilly published topline Phase 3 TRIUMPH-4 results
This is the traditional compounding we know and love - the doctor sends the pharmacy a prescription, they refer to the most appropriate Master Formulation Record, and then go on to compound an individual prescription for that specific patient
Una fase de carga acorta ese plazo a unos das, pero no mejora los resultados a largo plazo